Prepare FDA and CE mark submissions
regulatory-affairs-headskillsetup L3★17,464
alirezarezvani/claude-skills ↗What it does
Prepare FDA/EU submissions and regulatory strategy for medical devices
Best for
MedTech companies navigating 510(k), De Novo, PMA, or CE marking pathways.
Inputs
- · [object Object]
- · [object Object]
- · [object Object]
Outputs
- · [object Object]
- · [object Object]
- · [object Object]
Requires
- · FDA CDRH database
- · EU EUDAMED
- · Notified Body integrations
Preconditions
Device classification determined; intended use statement drafted; predicate identified (if applicable).
Failure modes
- · Predicate delisted mid-submission
- · Notified Body audit backlog (6+ month delay)
- · FDA deficiency letter on missing biocompatibility
- · New technology triggers De Novo instead of 510(k)
Trust signals
- · Pathway selection matrix (510(k) vs. De Novo vs. PMA)
- · Regulatory strategy document template
- · Workflow for Q-Sub meeting and pre-submission strategy